Treatment of hypophosphatemic rickets in generalized arterial calcification of infancy (GACI) without worsening of vascular calcification

Am J Med Genet A. 2016 May;170A(5):1308-11. doi: 10.1002/ajmg.a.37574. Epub 2016 Feb 9.

Abstract

Patients with generalized arterial calcification of infancy (GACI) develop vascular calcifications early in life. About half of them die within the first 6 months despite optimal medical care. A subset of those who survive eventually develop hypophosphatemic rickets. Since hypophosphatemia and hyperphosphaturia have been previously associated with increased survival in GACI patients, physicians often avoid phosphate repletion as treatment for rickets. As a consequence, GACI patients develop severe rachitic complications such as short stature and skeletal deformities. It appears that the recognition of hypophosphatemia later in life in some GACI patients is a consequence of having survived the first few months of life, and not the cause of their survival per se. Here, we report the long-term follow-up of a GACI patient who was phosphate-repleted for his rickets for more than 7 years without worsening of vascular calcification.

Keywords: ENPP1; generalized arterial calcification of infancy; hyperphosphaturia; hypophosphatemia; hypophosphatemic rickets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Follow-Up Studies
  • Humans
  • Male
  • Mutation
  • Phosphates / administration & dosage
  • Phosphoric Diester Hydrolases / genetics*
  • Pyrophosphatases / genetics*
  • Rickets, Hypophosphatemic / drug therapy*
  • Rickets, Hypophosphatemic / genetics
  • Rickets, Hypophosphatemic / physiopathology
  • Vascular Calcification / drug therapy*
  • Vascular Calcification / genetics
  • Vascular Calcification / physiopathology

Substances

  • Phosphates
  • Phosphoric Diester Hydrolases
  • ectonucleotide pyrophosphatase phosphodiesterase 1
  • Pyrophosphatases

Supplementary concepts

  • Arterial calcification of infancy